GlassScriptPhysician profile
Heidi L Braun
NPI 1942284856
$902.48
in general payments reported to CMS, 2019-2025
17 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2021: $79.16 · 2022: $217 · 2023: $169 · 2024: $106 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.18 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $164.22 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $160.77 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $78.42 | 2021-2025 | Slynd |
| Agile Therapeutics, INC. | $77.12 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $62.38 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Bayer Healthcare Pharmaceuticals INC. | $53.86 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $50.48 | 2022-2025 | |
| Pfizer INC. | $40.58 | 2024-2025 | |
| Hologic Sales and Service, LLC | $38.72 | 2019-2024 | Aptima |
| Sumitomo Pharma America, INC. | $36.70 | 2023 | Myfembree |
| Myovant Sciences INC. | $33.20 | 2022 | |
| Abbott Laboratories | $23.33 | 2023 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $21.88 | 2022 | |
| Therapeuticsmd, INC. | $17.92 | 2019 | |
| Avion Pharmaceuticals | $14.65 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $14.60 | 2019 | |
| Millicent US INC | $13.65 | 2024 | Femring, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.